CL2007003422A1 - Uso de un antagonista de la proteina pik3r3 para inhibir el crecimiento de un glioma que expresa dicha proteina; y metodo para diagnosticar la presencia de un glioma en un mamifero. - Google Patents
Uso de un antagonista de la proteina pik3r3 para inhibir el crecimiento de un glioma que expresa dicha proteina; y metodo para diagnosticar la presencia de un glioma en un mamifero.Info
- Publication number
- CL2007003422A1 CL2007003422A1 CL200703422A CL2007003422A CL2007003422A1 CL 2007003422 A1 CL2007003422 A1 CL 2007003422A1 CL 200703422 A CL200703422 A CL 200703422A CL 2007003422 A CL2007003422 A CL 2007003422A CL 2007003422 A1 CL2007003422 A1 CL 2007003422A1
- Authority
- CL
- Chile
- Prior art keywords
- protein
- gliom
- antigonist
- mammer
- pik3r3
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86776106P | 2006-11-29 | 2006-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007003422A1 true CL2007003422A1 (es) | 2008-06-20 |
Family
ID=39468664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200703422A CL2007003422A1 (es) | 2006-11-29 | 2007-11-28 | Uso de un antagonista de la proteina pik3r3 para inhibir el crecimiento de un glioma que expresa dicha proteina; y metodo para diagnosticar la presencia de un glioma en un mamifero. |
Country Status (11)
Country | Link |
---|---|
US (2) | US20080221014A1 (es) |
EP (1) | EP2091565A2 (es) |
JP (1) | JP2010511060A (es) |
AR (1) | AR064008A1 (es) |
AU (1) | AU2007325259A1 (es) |
CA (1) | CA2669184A1 (es) |
CL (1) | CL2007003422A1 (es) |
IL (1) | IL198425A0 (es) |
MX (1) | MX2009005400A (es) |
TW (1) | TW200831536A (es) |
WO (1) | WO2008067351A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5969483B2 (ja) * | 2010-09-23 | 2016-08-17 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | Gbm患者の生存を予測するために有用なテモゾロミドによるtop2a阻害 |
CN102321158B (zh) * | 2011-08-23 | 2013-03-27 | 常州德健生物科技有限公司 | 阻止细胞dna合成抑制细胞增殖的多肽及用途 |
JP2015501138A (ja) | 2011-10-07 | 2015-01-15 | ユニヴェルシテ モンペリエ ドゥ シアンス エ テクニックUniversite Montpellier 2 Sciences Et Techniques | 神経膠腫の予後予測 |
TWI692777B (zh) * | 2018-11-16 | 2020-05-01 | 長庚醫療財團法人高雄長庚紀念醫院 | 智能化急性腎損傷藥物警示系統 |
CN111778334A (zh) * | 2020-07-13 | 2020-10-16 | 中山大学孙逸仙纪念医院 | 一种CircRNA作为肝癌肿瘤标志物的评价方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6165170A (en) * | 1998-01-29 | 2000-12-26 | International Business Machines Corporation | Laser dermablator and dermablation |
CA2473039C (fr) * | 2002-01-18 | 2014-09-23 | Pierre Fabre Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
WO2004112829A2 (en) * | 2003-05-23 | 2004-12-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumors of glial origin |
WO2004108714A1 (en) * | 2003-06-05 | 2004-12-16 | Warner-Lambert Company Llc | Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
EP1689719A1 (en) * | 2003-11-25 | 2006-08-16 | Eli Lilly And Company | 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b) |
CA2598409A1 (en) * | 2005-02-17 | 2006-08-24 | Icos Corporation | Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
US20080014598A1 (en) * | 2006-07-13 | 2008-01-17 | Cell Signaling Technology, Inc. | Phospho-specific antibodies to pi3k regulatory subunit and uses thereof |
-
2007
- 2007-11-28 MX MX2009005400A patent/MX2009005400A/es not_active Application Discontinuation
- 2007-11-28 JP JP2009539450A patent/JP2010511060A/ja active Pending
- 2007-11-28 US US11/946,449 patent/US20080221014A1/en not_active Abandoned
- 2007-11-28 WO PCT/US2007/085709 patent/WO2008067351A2/en active Application Filing
- 2007-11-28 AR ARP070105279A patent/AR064008A1/es not_active Application Discontinuation
- 2007-11-28 TW TW096145233A patent/TW200831536A/zh unknown
- 2007-11-28 AU AU2007325259A patent/AU2007325259A1/en not_active Abandoned
- 2007-11-28 CA CA002669184A patent/CA2669184A1/en not_active Abandoned
- 2007-11-28 CL CL200703422A patent/CL2007003422A1/es unknown
- 2007-11-28 EP EP07868886A patent/EP2091565A2/en not_active Withdrawn
-
2009
- 2009-04-27 IL IL198425A patent/IL198425A0/en unknown
- 2009-07-06 US US12/498,181 patent/US20090269351A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2091565A2 (en) | 2009-08-26 |
TW200831536A (en) | 2008-08-01 |
WO2008067351A3 (en) | 2008-11-06 |
CA2669184A1 (en) | 2008-06-05 |
AR064008A1 (es) | 2009-03-04 |
AU2007325259A1 (en) | 2008-06-05 |
AU2007325259A2 (en) | 2009-07-02 |
IL198425A0 (en) | 2010-02-17 |
US20090269351A1 (en) | 2009-10-29 |
WO2008067351A2 (en) | 2008-06-05 |
JP2010511060A (ja) | 2010-04-08 |
MX2009005400A (es) | 2009-06-05 |
US20080221014A1 (en) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2575152T3 (es) | Combinación terapéutica y uso de anticuerpos antagonistas de DLL4 y agentes antihipertensores | |
NI200900081U (es) | Anticuerpos agonistas de trkb y sus usos. | |
BRPI0922885A2 (pt) | anticorpos humanos de alta afinidade para a pcsk9. | |
GT200800250A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
BRPI0914319A2 (pt) | anticorpos estáveis e solúveis que inibem tnfalfa | |
BRPI0906478A2 (pt) | anticorpo anti-nr10 e uso do mesmo | |
CU23871B1 (es) | Composiciones y métodos de uso para anticuerpos de dickkopf-1 | |
BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
CL2007003791A1 (es) | Compuestos derivados de piperidina, inhibidores de la proteina quinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para inhibir el crecimiento celular anormal. | |
BRPI0813306A2 (pt) | composto, composição farmacêutica, método para produzir a inibição de uma cisteína protease em um mamífero, e, uso de um composto. | |
BRPI0918141A2 (pt) | conjunto de embalagem para marinada sob demanda e método para fornecer o mesmo | |
DK1981853T3 (da) | Substituerede imidazoler samt anvendelse deraf som pesticider | |
BRPI0716327A2 (pt) | Composto de fenilpropionamida e uso | |
CL2013000098A1 (es) | Composicion farmaceutica que contienen una formulacion activada y potenciada de un anticuerpo para el receptor canabinoide humano; metodos de uso. | |
CL2007002837A1 (es) | Uso de fenitoina para tratar mucositis oral. | |
NO20081618L (no) | Anvendelse av proteiner som en antiskumdannende komponent i drivstoff | |
CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
BRPI0909885A2 (pt) | composição decorativa e método para sua utilização | |
BRPI0717496A2 (pt) | Polímeros ramificados e métodos para sua síntese e uso | |
BRPI0817542A2 (pt) | NOVOS INIBIDORES DE sEH E SEU USO | |
CL2007000355A1 (es) | Combinacion que comprende un inhibidor de quinasas dependiente de ciclinas, un anticuerpo que inhibe un factor de crecimiento y un agente antimitotico; composicion farmaceutica que la comprende; y su uso para tratar un trastorno proliferativo. | |
DK1828649T3 (da) | Tryksatte fluidcylindre | |
CL2007003422A1 (es) | Uso de un antagonista de la proteina pik3r3 para inhibir el crecimiento de un glioma que expresa dicha proteina; y metodo para diagnosticar la presencia de un glioma en un mamifero. | |
CL2013001565A1 (es) | Metodo para tratar la ingesta excesiva o comer compulsivamente, que comprende el uso de bupropion y naltrexona y la composicion farmaceutica que comprende a ambos compuestos. | |
BRPI0807989A2 (pt) | Composto de éster e uso do mesmo. |